$COR News

Cencora's Q4 2026 Earnings: What to Expect

Is American Oncology Network (AONC) Fully Valued Following Cencora's $2.4b Buyout Deal?

Baird Maintains Outperform on Cencora, Raises Price Target to $375

Cencora to Acquire American Oncology Network to Strengthen Support of Community Oncology

Here’s How Much You Would Have Made Owning Cencora Stock In The Last 5 Years

Cencora Agrees To Acquire Remaining Stake In American Oncology Network For $2.4B

Argus Research Maintains Buy on Cencora, Raises Price Target to $380

Cencora (COR): 3 Reasons We Love This Stock

Is Cencora (COR) Undervalued Or Is Raised Guidance Already Priced In?

UBS Maintains Buy on Cencora, Lowers Price Target to $400

If You Invested $1000 In Cencora Stock 10 Years Ago, You Would Have This Much Today

Cencora Q3 2026 Earnings Call Transcript

Leerink Partners Maintains Outperform on Cencora, Raises Price Target to $388

Cencora Remains A Buy At These Prices, As Healthcare Supply-Chain Needs Grow

Cencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings Release

$100 Invested In Cencora 5 Years Ago Would Be Worth This Much Today

Cencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at Conference

Cencora (COR) Lifts EPS Outlook And Buyback, Is The Stock Still Below Fair Value?

Cencora (COR) Raised Guidance and Bought Back $1B. What’s the Catch?

Cencora Tech Chief: AI Is Cutting Some Medical Treatment Decisions in Half